OCC 1.37% 37.0¢ orthocell limited

Remplir will get to market, the product has standout benefits,...

  1. 1,189 Posts.
    lightbulb Created with Sketch. 122
    Remplir will get to market, the product has standout benefits, it is only a matter of time.

    Striate is also an amazing product that has also shown the company has the ability to commercialise products with world leading distributors. The take up of Striate in the marketplace has already surpassed company expectations in this very early stage of commercialisation.

    The future is very bright, I expect $5 plus is not unrealistic upon Remplir achieving US approval.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
0.005(1.37%)
Mkt cap ! $77.54M
Open High Low Value Volume
37.0¢ 37.0¢ 37.0¢ $4.309K 11.64K

Buyers (Bids)

No. Vol. Price($)
2 2629 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 9866 1
View Market Depth
Last trade - 15.34pm 19/08/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.